Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins

Yong Zhang,Xinsheng Gao,Leslie J. Saucedo,Binggen Ru,Bruce A. Edgar,Duojia Pan
DOI: https://doi.org/10.1038/ncb999
IF: 21.3
2003-01-01
Nature Cell Biology
Abstract:Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans 1 , 2 . Tsc2 possesses a domain that shares homology with the GTPase-activating protein (GAP) domain of Rap1-GAP 2 , suggesting that a GTPase might be the physiological target of Tsc2. Here we show that the small GTPase Rheb (Ras homologue enriched in brain) is a direct target of Tsc2 GAP activity both in vivo and in vitro . Point mutations in the GAP domain of Tsc2 disrupted its ability to regulate Rheb without affecting the ability of Tsc2 to form a complex with Tsc1. Our studies identify Rheb as a molecular target of the TSC tumour suppressors.
What problem does this paper attempt to address?